We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current NVAX market cap is 1.11B. The company's latest EPS is USD -1.1576 and P/E is -5.91.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 93.86M | 415.48M | 84.51M | 88.31M | 666.66M |
| Operating Income | -144.83M | 161M | -130.26M | -134.84M | 515.51M |
| Net Income | -147.55M | 162.38M | -121.3M | -81.03M | 518.65M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 475.6M | 1.15B | 1.98B | 983.71M | 682.16M |
| Operating Income | -416.72M | -1.69B | -644.74M | -566.51M | -248.93M |
| Net Income | -418.26M | -1.74B | -657.94M | -545.06M | -187.5M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.35B | 1.82B | 1.71B | 1.56B | 1.29B |
| Total Liabilities | 2.22B | 2.25B | 2.24B | 2.18B | 1.37B |
| Total Equity | -867.08M | -431.71M | -526.44M | -623.84M | -75.64M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.58B | 2.58B | 2.26B | 1.8B | 1.56B |
| Total Liabilities | 955.27M | 2.93B | 2.89B | 2.51B | 2.18B |
| Total Equity | 627.21M | -351.67M | -634.08M | -716.93M | -623.84M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -83.56M | 230.71M | 85.9M | -87.26M | -185.5M |
| Investing | -7.25M | -379.96M | -348.05M | -204.04M | -73.32M |
| Financing | 5.89M | 264.1M | 262.03M | 260.58M | -7.06M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -42.54M | 322.95M | -415.94M | -713.97M | -87.26M |
| Investing | -377.78M | 100.15M | -92.99M | -58.81M | -204.04M |
| Financing | 984.76M | 461.71M | 324.99M | 4.47M | 260.58M |
| Market Cap | 1.11B |
| Price to Earnings Ratio | -5.91 |
| Price to Sales Ratio | 1.62 |
| Price to Cash Ratio | 2.09 |
| Price to Book Ratio | -1.78 |
| Dividend Yield | - |
| Shares Outstanding | 161.97M |
| Average Volume (1 week) | 4.7M |
| Average Volume (1 Month) | 4.96M |
| 52 Week Change | -44.26% |
| 52 Week High | 17.81 |
| 52 Week Low | 5.01 |
| Spread (Intraday) | 0.49 (7.01%) |
| Company Name | Novavax Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.novavax.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
